Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 4421 of 5804
-
New tooth gel could zap sensitivity pain
Symptom relief CompletedEvaluate the safety and clinical efficacy of new dental desensitizers in the treatment of dentin sensitivity, including the relief of sensitivity symptoms and the duration of efficacy.
Phase: NA • Sponsor: Peking University Hospital of Stomatology • Aim: Symptom relief
Last updated Jun 27, 2026 09:06 UTC
-
Russian lung cancer care under the microscope: 1500 patients tracked
Knowledge-focused OngoingPlanned study population consists of approximately 1500 adult patients with a/m NSCLC in Russia, in about 20 oncological centers (in each center it is expected to recruit about 75 patients) in different regions of Russia in order to provide representative study sample
Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
New stent shows promise for quicker heart vessel healing
Disease control OngoingTo evaluate the stent endothelialization (\> 20 microns) of VIVO ISARTM versus XIENCE SkypointTM stents at 1-month (very early strut covered) at follow-up by Optical Coherence Tomography (OCT) implanted IN THE SAME PATIENT during routine clinical practice.
Phase: NA • Sponsor: Fundación EPIC • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Vitamin D3 may lower long COVID risk, new study suggests
Knowledge-focused CompletedThe aim of this observational retrospective study is to evaluate the effect of supplementation with cholecalciferol D3 in reducing the risk of: * occurence of Long COVID syndrome after acute COVID-19 illness * occurence of SARS-CoV-2 infection after anti-COVID-19 vaccination
Sponsor: IRCCS San Raffaele • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:05 UTC
-
Drama therapy boosts student Well-Being in small trial
Symptom relief CompletedThis study is a randomized controlled trial designed to evaluate the effectiveness of a structured psychodrama-based intervention on psychological well-being, empathy, self-compassion, and personality-related characteristics among undergraduate nursing students. The study will b…
Phase: NA • Sponsor: Ministry of Health, Turkey • Aim: Symptom relief
Last updated Jun 27, 2026 12:03 UTC
-
Lung cancer study reveals hidden toll of muscle loss during targeted therapy
Knowledge-focused CompletedNutritional assessment of patients with non-small cell lung cancer treated with osimertinib. Non-small-cell lung cancer (NSCLC) accounts for approximately 85% of all lung cancer cases and is a leading cause of morbidity and mortality worldwide. Between 35% and 65% of NSCLC patie…
Sponsor: Fundacin Biomedica Galicia Sur • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:25 UTC
-
Smart sensors track hidden heart risks in duchenne MD
Knowledge-focused Recruiting nowDuchenne muscular dystrophy (DMD) is an X-linked disorder that causes muscle wasting, cardiopulmonary failure, and premature death. Heart failure is a leading cause of death in DMD, but substantial knowledge gaps exist regarding predisposing risk factors. In the general populatio…
Sponsor: Vanderbilt University Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC
-
New study aims to pinpoint fastest Crohn's symptom relief
Knowledge-focused Recruiting nowThe primary aim of this study is to explore the time course of response to Vedolizumab in participants with CD as measured by the Patient-Reported Outcomes Measurement Information System (PROMIS) Pain Interference-short form (SF), as well as other PROMIS domain SFs (fatigue, anxi…
Sponsor: Alimentiv Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:04 UTC
-
New schizophrenia shot could replace daily pills
Disease control CompletedThe primary objective of the study is to evaluate the comparative bioavailability of TV-44749 administered subcutaneous (sc) to oral olanzapine (ZYPREXA®) at steady state in participants with schizophrenia. A secondary objective of this trial is to evaluate the safety and tolera…
Phase: PHASE1 • Sponsor: Teva Branded Pharmaceutical Products R&D LLC • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
New combo therapy aims to sharpen thinking and social skills in older schizophrenia patients
Knowledge-focused OngoingThe purpose of this research study to test a blended intervention that combines Executive Function Training with Cognitive-Behavioral Skills Training (E-CBSST). The aims include determining whether E-CBSST is feasible and increases Cognitive Behavioral Social Skills Training (CBS…
Phase: NA • Sponsor: University of California, San Diego • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:56 UTC
-
Ritalin may change how the brain reacts to alcohol triggers
Knowledge-focused CompletedThe purpose of this study is to determine whether changes in attention levels related to taking a single dose of a medication called methylphenidate, also known as Ritalin, affects responses to alcohol cues. The study will observe the effects of methylphenidate or a placebo on at…
Phase: EARLY_PHASE1 • Sponsor: University of Florida • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:03 UTC
-
New Botox-Like injection aims to smooth frown lines safely
Symptom relief CompletedThis is a Multi-center, Open-label Study on the Efficacy and Safety of Multiple Treatments with Recombinant Botulinum Toxin Type A for Injection in the Treatment of Moderate to Severe Glabellar Lines. The study has been designed to evaluate the long-term safety, tolerability, eff…
Phase: PHASE3 • Sponsor: Chongqing Claruvis Pharmaceutical Co., Ltd. • Aim: Symptom relief
Last updated Jul 01, 2026 00:00 UTC
-
Can a new therapy curb violence in young psychosis patients?
Disease control OngoingThis study aims to provide an evidence-based behavioral intervention to reduce violent behavior for individuals experiencing early psychosis.
Phase: NA • Sponsor: Columbia University • Aim: Disease control
Last updated Jun 26, 2026 13:24 UTC
-
Scientists probe Esketamine's Mind-Altering side effects
Knowledge-focused CompletedKetamine is an anaesthetic used in low doses to treat depressive disorders. A related molecule, Esketamine, has recently been launched on the market for the treatment of resistant depression. One of the side effects of ketamine, like Esketamine, is induction of transient dissocia…
Phase: NA • Sponsor: Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer • Aim: Knowledge-focused
Last updated Jul 09, 2026 00:00 UTC
-
New wheelchair adapts to spasms, promises better comfort and safety
Symptom relief CompletedThis study compares two modes of the NETTI wheelchair (dynamic or sitting) for patients with hyperkinetic syndromes, to discover which mode is the most comfortable and best suited to these patients. It is a prospective, single-center pilot study comparing two medical devices eva…
Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Symptom relief
Last updated Jun 27, 2026 08:02 UTC
-
New cancer drug tested in 13 patients – early trial ends
Disease control TerminatedThis is an open-label, multicenter Phase 1 clinical trial to evaluate the safety and tolerability, efficacy, and pharmacokinetics of SIM0501 in participants with advanced solid tumors. The trial consists two parts, Part 1 for SIM0501 monotherapy and Part 2 for SIM0501 in combinat…
Phase: PHASE1 • Sponsor: Jiangsu Simcere Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
Can telemedicine help prevent blindness in diabetes patients?
Knowledge-focused OngoingThis study is being conducted to test the effectiveness of I-SITE (Implementation for Sustained Impact in Teleophthalmology), an implementation program to sustain increased diabetic eye screening rates using teleophthalmology in urban, multi-payer health systems.
Phase: NA • Sponsor: University of Wisconsin, Madison • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:05 UTC
-
Exercise program aims to get head and neck cancer patients off the couch
Symptom relief Recruiting nowAPAORL2 study aims to evaluate the efficacy of a physical activity program on the sedentary and physical activity level during the 18-month program. APAORL2 study is a randomized, open label, controlled, monocentric, intervention study that will be conducted among 96 patients tr…
Phase: NA • Sponsor: Centre Hospitalier de Valence • Aim: Symptom relief
Last updated Jun 27, 2026 11:03 UTC
-
New stitch could speed up hysterectomy surgery
Disease control Recruiting nowThe aim of this study is to show the superiority of the new unidirectional barbed suture (SYMMCORA® mid-term, unidirectional) to conventional suture material in terms of time to perform the vaginal cuff closure during gynecologic surgeries without an increase in the complication …
Sponsor: Aesculap AG • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Zoom music therapy boosts Seniors' Well-Being, small study hints
Symptom relief CompletedThis study investigates the benefits of using telehealth services, specifically a combination of music therapy and social work support, to improve the well-being of older adults. Investigators are focusing on outcomes such as reduced loneliness, improved cognition, and how well o…
Phase: NA • Sponsor: Alaine E Hernandez, PhD • Aim: Symptom relief
Last updated Jun 26, 2026 12:54 UTC